Thanks to Wounds Australia Platinum Partner Essity for this update on their work with the Federal Government's Chronic Wound Consumables Scheme.

The Chronic Wound Consumables Scheme (CWCS) is a government-funded initiative launched in May this year designed to reduce the financial burden of wound care and improve healing outcomes, by ensuring patients have access to the right products at the right time. The scheme provides essential wound care products at no cost, to eligible Australians living with diabetes and a chronic wound.

As a preferred supplier on the CWCS, Essity are here to support you in healing your patients. Their reliable wound management and compression portfolios – Leukoplast®, Cutimed® and JOBST® – combine advanced technologies with easy-to-use products, empowering you to deliver care with confidence. 

With 200+ products listed on the scheme across multiple categories, Essity has a solution no matter the stage and clinical need of the wound. Visit Essity's CWCS webpage for their full list of available products, as well as additional information on the scheme.

Cutimed® Sorbion: Setting the Standard for Exudate Management

With its impressive Sorbion Technology, Cutimed Sorbion provides best in class exudate management1 to overcome any exudate challenge, with up to 44% more absorption than other superabsorbents1 and being more than 4x more absorbent than foam dressings.2 

Cellulose fibres within the superabsorbent core rapidly absorb exudate away from the wound. Once exudate has been absorbed, the superabsorbent core forms a soft gel with a moist outer shell. The design of Sorbion Technology promotes a moist wound environment on the wound side of the product, while excess exudate is efficiently transported away from the wound. This helps to prevent wound maceration, promote moist wound healing, and leads to the removal of wound healing inhibiting factors, including bacteria, MMPs, proteases, and inflammatory mediators.3,4 

With the complete range of Sorbion variants, shapes, and sizes available on the CWCS, there is a solution for any exudate level, any wound shape, located anywhere.

First with JOBST: Right Compression, Right from the Start

Leg ulceration is typically a chronic recurring condition with episodes of ulceration ranging from weeks to more than 10 years, often resulting in significant distress and associated costs. 

The most common cause of lower extremity ulceration is chronic venous insufficiency due to calf muscle pump dysfunction. Compression therapy has two mechanisms of action: a static effect or resting pressure and a dynamic effect due to the changing circumference of the leg during walking. 

Compression increases ulcer healing rates compared with no compression. The type of compression system also influences healing rate: multicomponent systems are more effective than single component systems, and those with an elastic component are more effective than those with inelastic components.5 

The CWCS offers JOBST compression solutions to support best practice in wound healing. Learn more about JOBST FarrowWrap compression systems, JOBST Compri2 two-layered bandage systems, and JOBST UlcerCare two-in-one compression garment system by visiting the Essity CWCS webpage or www.jobst.com.au.

Cutimed® Wound Navigator: Your Digital Sidekick

With a multitude of consumables available on the CWCS, choosing the right dressing for the wound can become overwhelming. Trust in Cutimed® Wound Navigator, the free smart app simplifying wound assessment and product selection in three simple steps. 

1. Measure: wound size using the camera function and calibration markers. 
2. Select: the relevant wound assessment criteria. 
3. Find: the right product for the wound as recommended by the app, and order through the CWCS portal.

Visit Essity's CWCS webpage.

Wounds Australia partners

This article was brought to you by our valued Platinum Partner Essity. Wounds Australia partners with industry leaders like Essity  to help achieve our mission of minimising the harm caused by chronic wounds. Find out more.

1 Essity Group – Commissioned laboratory testing at SMTL.; Evaluation of absorbency and fluid retention of different superabsorbent wound dressings (based on EN 13726). 2024. 

2 Essity Group. SMTL: Wound dressing report. 2025. 

3 Cutting KF. Managing wound exudate using a super-absorbent polymer dressing: a 53-patient clinical evaluation. J Wound Care 2009;18(5):200-205. 

4 Wiegand C et al. SAP-containing dressings exhibit sustained antimicrobial effects over 7 days in vitro. J Wound Care. 2013;22(3):120-127. 5 Royal Australian College of General Practitioners (RACGP), 2017. Compression for venous leg ulcers. Available at: https://www.racgp.org.au/clinical-resources/clinical-guidelines/handi/handi-interventions/procedures/compression-for-venous-leg-ulcers